{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:23Z","timestamp":1791919103070,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:00:00Z","timestamp":1635897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007190","name":"Unilever","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.yrtph.2021.105075","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T10:55:30Z","timestamp":1635591330000},"page":"105075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products"],"prefix":"10.1016","volume":"127","author":[{"given":"G.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Gilmour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cubberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Spriggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aptula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Przybylak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Windebank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Baltazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yrtph.2021.105075_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/toxsci\/kfp030","article-title":"Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment","volume":"108","author":"Aleksic","year":"2009","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105075_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/cod.13119","article-title":"Prevalence of contact allergy in the general population: a systematic review and meta-analysis","volume":"80","author":"Alinaghi","year":"2019","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yrtph.2007.10.008","article-title":"Dermal sensitization quantitative risk assessment (qra) for fragrance ingredients","volume":"52","author":"Api","year":"2008","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0536.2007.00944.x","article-title":"Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles","volume":"56","author":"Aptula","year":"2007","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/taap.1997.8154","article-title":"Comparativein vitroskin absorption and metabolism of coumarin (1,2-benzopyrone) in human, rat, and mouse","volume":"145","author":"Beckley-Kartey","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.105075_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: a workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Computational Toxicology"},{"issue":"5","key":"10.1016\/j.yrtph.2021.105075_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1124\/dmd.30.5.483","article-title":"Identification of the cytochromes p450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation","volume":"30","author":"Born","year":"2002","journal-title":"Drug Metab. Dispos.: the biological fate of chemicals"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/58.1.23","article-title":"In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity","volume":"58","author":"Born","year":"2000","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2021.105075_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.comtox.2018.06.001","article-title":"Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients","volume":"7","author":"Dent","year":"2018","journal-title":"Computational Toxicology"},{"issue":"3","key":"10.1016\/j.yrtph.2021.105075_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/tx0341456","article-title":"Protein binding and metabolism influence the relative skin sensitization potential of cinnamic compounds","volume":"17","author":"Elahi","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2021.105075_bib12","doi-asserted-by":"crossref","unstructured":"Garcia-Canton C, Minet E. Metabolic characterization of cell systems used in in vitro toxicology testing. Encyclopedia of Drug Metabolism and Interactions. p. 1-31.","DOI":"10.1002\/9780470921920.edm142"},{"key":"10.1016\/j.yrtph.2021.105075_bib13","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.yrtph.2020.104755","article-title":"Read-across can increase confidence in the next generation risk assessment for skin sensitisation: a case study with resorcinol","volume":"117","author":"Gautier","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.105075_bib14","doi-asserted-by":"crossref","first-page":"104721","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.105075_bib15","series-title":"Next generation risk assessment for skin allergy: decision making using new approach methodologies","author":"Gilmour","year":"2021"},{"issue":"5","key":"10.1016\/j.yrtph.2021.105075_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (i): the cosmetics europe database","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2021.105075_bib17","series-title":"The Ifra Standard on Coumarin, 48th Amdendment","year":"2015"},{"issue":"9","key":"10.1016\/j.yrtph.2021.105075_bib18","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.drudis.2019.06.002","article-title":"Skin metabolism phase i and phase ii enzymes in native and reconstructed human skin: a short review","volume":"24","author":"Kazem","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.yrtph.2021.105075_bib19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (ii): an assessment of defined approaches (*)","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfx236","article-title":"Predicting drug safety and communicating risk: benefits of a bayesian approach","volume":"162","author":"Lazic","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105075_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tiv.2005.08.001","article-title":"Metabolism of coumarin by human p450s: a molecular modelling study","volume":"20","author":"Lewis","year":"2006","journal-title":"Toxicol. Vitro"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/toxsci\/kfy135","article-title":"Deriving a no expected sensitization induction level for fragrance ingredients without animal testing: an integrated approach applied to specific case studies","volume":"165","author":"Natsch","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2021.105075_bib23","series-title":"Test no. 429: skin sensitisation","year":"2010"},{"key":"10.1016\/j.yrtph.2021.105075_bib24","series-title":"The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins","year":"2014"},{"key":"10.1016\/j.yrtph.2021.105075_bib25","series-title":"Guidance document on the reporting of defined approaches and individual information sources to be used within integrated approaches to testing and assessment (iata) for skin sensitisation","year":"2017"},{"key":"10.1016\/j.yrtph.2021.105075_bib26","series-title":"Test no. 442d: in vitro skin sensitisation","year":"2018"},{"key":"10.1016\/j.yrtph.2021.105075_bib27","series-title":"Test no. 442e: in vitro skin sensitisation","year":"2018"},{"key":"10.1016\/j.yrtph.2021.105075_bib28","series-title":"Test no. 442c: in chemico skin sensitisation","year":"2019"},{"key":"10.1016\/j.yrtph.2021.105075_bib29","volume":"vol. 4","year":"2021"},{"issue":"12","key":"10.1016\/j.yrtph.2021.105075_bib30","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00204-014-1382-8","article-title":"Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, Guinea pig, man, and in human skin models","volume":"88","author":"Oesch","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2021.105075_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yrtph.2017.06.002","article-title":"Binary test battery with keratinosens\u2122 and h-clat as part of a bottom-up approach for skin sensitization hazard prediction","volume":"88","author":"Otsubo","year":"2017","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"key":"10.1016\/j.yrtph.2021.105075_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.yrtph.2016.08.007","article-title":"Can currently available non-animal methods detect pre and pro-haptens relevant for skin sensitization?","volume":"82","author":"Patlewicz","year":"2016","journal-title":"Regul. Toxicol. Pharmacol. : RTP (Regul. Toxicol. Pharmacol.)"},{"key":"10.1016\/j.yrtph.2021.105075_bib33","doi-asserted-by":"crossref","first-page":"100144","DOI":"10.1016\/j.comtox.2020.100144","article-title":"The role of validation in establishing the scientific credibility of predictive toxicology approaches intended for regulatory application","volume":"17","author":"Patterson","year":"2021","journal-title":"Computational Toxicology"},{"key":"10.1016\/j.yrtph.2021.105075_bib34","series-title":"Decision making in next generation risk assessment for skin allergy: using historical clinical experience to benchmark risk","author":"Reynolds","year":"2021"},{"key":"10.1016\/j.yrtph.2021.105075_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.comtox.2018.10.004","article-title":"Probabilistic prediction of human skin sensitiser potency for use in next generation risk assessment","volume":"9","author":"Reynolds","year":"2019","journal-title":"Computational Toxicology"},{"issue":"2","key":"10.1016\/j.yrtph.2021.105075_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acs.chemrestox.6b00241","article-title":"Structure-potency relationships for epoxides in allergic contact dermatitis","volume":"30","author":"Roberts","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2021.105075_bib37","series-title":"Sccs (scientific committee on consumer safety), opinion on fragrance allergens in cosmetic products","year":"2012"},{"key":"10.1016\/j.yrtph.2021.105075_bib38","series-title":"Sccs notes of guidance for the testing of cosmetic ingredients and their safety evaluation 11th revision","first-page":"30","year":"2021"},{"issue":"4","key":"10.1016\/j.yrtph.2021.105075_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/acs.chemrestox.5b00410","article-title":"Reactive metabolites: current and emerging risk and hazard assessments","volume":"29","author":"Thompson","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"5","key":"10.1016\/j.yrtph.2021.105075_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/acs.chemrestox.6b00055","article-title":"Assessment of pre- and pro-haptens using nonanimal test methods for skin sensitization","volume":"29","author":"Urbisch","year":"2016","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105075_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1570-0232(03)00473-2","article-title":"Liquid chromatographic determination of the glutathione conjugate and ring-opened metabolites formed from coumarin epoxidation","volume":"794","author":"Vassallo","year":"2003","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.yrtph.2021.105075_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000358272","article-title":"Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system","volume":"27","author":"Wiegand","year":"2014","journal-title":"Skin Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105075_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acs.chemrestox.9b00264","article-title":"Predicting drug-induced liver injury with bayesian machine learning","volume":"33","author":"Williams","year":"2019","journal-title":"Chem. Res. Toxicol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:33:40Z","timestamp":1759494820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230021002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"alternative-id":["S0273230021002166"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.105075","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.105075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105075"}}